| __timestamp | Dynavax Technologies Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 24518692 |
| Thursday, January 1, 2015 | 22180000 | 19886580 |
| Friday, January 1, 2016 | 37257000 | 12631689 |
| Sunday, January 1, 2017 | 27367000 | 21977998 |
| Monday, January 1, 2018 | 64770000 | 20759000 |
| Tuesday, January 1, 2019 | 74986000 | 20838000 |
| Wednesday, January 1, 2020 | 79256000 | 121812000 |
| Friday, January 1, 2021 | 100156000 | 152137000 |
| Saturday, January 1, 2022 | 131408000 | 83231000 |
| Sunday, January 1, 2023 | 152946000 | 122706000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial. This chart provides a fascinating glimpse into the Selling, General, and Administrative (SG&A) expenses of two prominent biotech firms: Dynavax Technologies Corporation and TG Therapeutics, Inc., from 2014 to 2023.
Dynavax has shown a consistent upward trend in SG&A expenses, peaking in 2023 with a 760% increase from 2014. This growth reflects their aggressive expansion and investment in marketing and administrative capabilities.
TG Therapeutics, on the other hand, experienced a more volatile trajectory. Their SG&A expenses surged by 500% in 2021, coinciding with significant product launches, before stabilizing in subsequent years.
This comparison highlights the strategic differences in cost management between these two companies, offering valuable insights for investors and industry analysts.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Novartis AG and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Who Optimizes SG&A Costs Better? Catalent, Inc. or Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Dynavax Technologies Corporation
MannKind Corporation and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV
SG&A Efficiency Analysis: Comparing Dynavax Technologies Corporation and Novavax, Inc.